我要投票 钙立速在补钙行业中的票数:6
· 外 推 电 报 ·
2024-11-21 20:36:18 星期四

【钙立速是哪个国家的品牌?】

钙立速是什么牌子?「钙立速」是 三亚百泰生物科技有限公司 旗下著名品牌。该品牌发源于海南,由创始人张立在2010期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

钙立速-纳米天门冬氨酸螯合钙使用的是气穴崩塌原理,使天门冬氨酸和氢氧化钙充分进行乳化分散,纳米破碎,颗粒度达2-80纳米,可以被小肠粘膜细胞识别直接吸收,不需添加维生素D3的强化,吸收率达90%以上,改善了现代人体对钙的需求。

公司研发生产的纳米氨基酸螯合钙将打造成纳米螯合技术发展的核心和主流方向,改变传统钙的吸收问题和人体吸收过程中的副作用问题,此项生产工艺已获得国家专利,在纳米螯合钙技术上取得重大突破,并已被市场广泛接受及应用。

三亚百泰生物科技有限公司,是一家集研发、生产、销售为一体的高新技术企业,公司以“资源优化整合,发挥联动互效”为宗旨,努力促进以科技与产业接轨、产品与市场接轨的系统工程,公司积极开展国际化技术转化的同时,专注于培育自主创新能力,多年来组织多学科专家连续进行前期试验和研发工作,在一批学者的共同努力下,先后研制出L-天门冬氨酸纳米螯合钙、土壤保墒材料和果蔬保鲜技术等一系列科研成果。正在开发的新产品包括纳米材料、南药研发、土壤保墒、海洋生物等方面,专注创新的研发成果将为国人创造无限价值。百泰生物科技有限公司现有员工50多名,大学本科占80%以上,其中科研人员占50%以上。

公司研发生产的纳米天门冬氨酸螯合钙使用的是气穴崩塌原理,使天门冬氨酸和氢氧化钙充分进行乳化分散,纳米破碎,颗粒度达2-80纳米,可以被小肠粘膜细胞识别直接吸收,不需添加维生素D3的强化,吸收率达90%以上,改善了现代人体对钙的需求。公司研发生产的纳米氨基酸螯合钙将打造成纳米螯合技术发展的核心和主流方向,改变传统钙的吸收问题和人体吸收过程中的副作用问题,此项生产工艺已获得国家专利,在纳米螯合钙技术上取得重大突破,并已被市场广泛接受及应用。

公司利用新一代纳米技术,结合海南南药及海洋生物的优势,将不断研制出更多新产品,同时开拓纳米技术在中药领域的应用,加快推进‘纳米中药’从理论变为现实的进程,突破创新的研发成果将为国人创造价值,在实现经济效益的同时创造更高的社会效益。

目前三亚百泰生物科技有限公司在三亚创意产业园投资生产基地的二期建设项目,完全建成后的纳米氨基酸螯合钙生产基地年产量为 1200 吨,执照打造成大型的纳米螯合钙生产基地,为我国食品、乳制品行业从传统产品向功能产品的转化提供坚实后盾;为医药中间体的发展,提供新型科技成果、新型的原料保障。

英文翻译:Calcium standing speed - nanometer aspartic acid chelate calcium uses the principle of cavitation collapse, which makes aspartic acid and calcium hydroxide fully emulsified and dispersed, nanometer broken, particle size up to 2-80 nm, which can be recognized and directly absorbed by small intestinal mucosal cells, without adding vitamin D3 to strengthen, and the absorption rate is over 90%, which improves the demand of modern human body for calcium. The nano amino acid chelated calcium developed and produced by the company will be the core and mainstream direction of the development of nano chelating technology, which will change the absorption of traditional calcium and the side effects in the absorption process of human body. This production process has obtained national patent, made a major breakthrough in nano chelated calcium Technology, and has been widely accepted and applied in the market. Sanya Baitai Biotechnology Co., Ltd. is a high-tech enterprise integrating R & D, production and sales. With the tenet of "optimizing and integrating resources, giving full play to linkage and mutual effect", the company strives to promote systematic engineering integrating technology with industry, products with market. While actively carrying out international technology transformation, the company focuses on cultivating independent innovation ability. Over the years, the company Organize multi-disciplinary experts to carry out the preliminary test and research and development work continuously. With the joint efforts of a group of scholars, a series of scientific research achievements have been successively developed, such as L-aspartic acid nano chelate calcium, soil moisture preservation materials, fruits and vegetables preservation technology. The new products under development include nano materials, research and development of South medicine, soil moisture conservation, marine biology, etc. the research and development achievements focused on innovation will create infinite value for Chinese people. Baitai Biotechnology Co., Ltd. has more than 50 employees, more than 80% of which are undergraduates, and more than 50% of which are scientific researchers. The nano-sized calcium aspartate chelate developed and produced by the company is based on the principle of cavitation collapse, which enables the full emulsification and dispersion of aspartic acid and calcium hydroxide. The nano particle size is up to 2-80 nm, which can be recognized and directly absorbed by the intestinal mucosal cells without the reinforcement of vitamin D3. The absorption rate is up to 90%, which improves the demand of modern human body for calcium. The nano amino acid chelated calcium developed and produced by the company will be the core and mainstream direction of the development of nano chelating technology, which will change the absorption of traditional calcium and the side effects in the absorption process of human body. This production process has obtained national patent, made a major breakthrough in nano chelated calcium Technology, and has been widely accepted and applied in the market. Using the new generation of nanotechnology, combined with the advantages of Hainan Southern medicine and marine biology, the company will continue to develop more new products, at the same time, expand the application of nanotechnology in the field of traditional Chinese medicine, accelerate the process of "nano traditional Chinese medicine" from theory to reality, and the breakthrough of innovative research and development results will create value for Chinese people and create higher social benefits while realizing economic benefits. At present, Sanya Baitai Biotechnology Co., Ltd. has invested in the second phase of the production base of Sanya creative industrial park. The annual output of the completed nano amino acid calcium chelate production base is 1200 tons. The license has been built into a large-scale nano calcium chelate production base, providing solid support for the transformation of China's food and dairy industry from traditional products to functional products, and for the transformation of pharmaceutical intermediates To provide new scientific and technological achievements and new material guarantee.

本文链接: https://www.waitui.com/brand/a6f0f985f.html 联系电话:18976599440

千城特选小程序码

7×24h 快讯

拼多多:第三季度营收增速环比下降,将坚定高质量发展战略应对竞争挑战

36氪获悉,拼多多发布2024年第三季度财报。财报显示,本季度拼多多营收达到994亿元,与上个季度相比,营收的增速有所放缓。业内分析认为,一方面是因为电商行业的竞争依然激烈,另一方面是平台的“百亿减免”等举措影响了短期的财报表现。“为了应对行业竞争,我们将坚定地执行高质量发展战略,继续实行‘减免+扶持’的举措,持续完善平台及产业生态,为供需两侧带来更大的普惠。”拼多多陈磊表示。

37分钟前

拼多多:第三季度利润环比下降22%,将长期投入“新质供给”“电商西进”战略

36氪获悉,拼多多发布2024年第三季度财报。财报显示,本季度拼多多利润达到250亿元,环比下降22%。过去这个季度,拼多多先后推出“百亿减免”“电商西进”“新质商家扶持计划”等重磅举措,持续扩大对生态建设的投资,一定程度上影响了短期的财报表现。拼多多陈磊表示,在财务数据之外,我们更加看重生态投资带来的长期价值,未来几个季度,拼多多将继续投入“新质供给”“电商西进”等战略,给用户、商家及产业带来更长远的回报。

37分钟前

莎普爱思:股东拟合计减持不超5%公司股份

36氪获悉,莎普爱思公告,股东陈德康持有公司12.39%股份,上海景兴实业投资有限公司持有公司4.7%股份。陈德康计划减持公司股份数量合计不超过758.32万股,即不超过公司总股本的2%。上海景兴计划减持公司股份数量合计不超过1137.48万股,即不超过公司总股本的3%。

37分钟前

永杰新材上交所主板IPO申请获证监会同意注册批复

36氪获悉,证监会下发关于同意永杰新材料股份有限公司首次公开发行股票注册的批复,同意该公司首次公开发行股票的注册申请。根据招股书,该公司拟在上交所主板上市,公司专业从事铝板带箔的研发、生产与销售,产品主要包括铝板带和铝箔两大类。

37分钟前

东方电缆:公司及子公司近期中标合计约40亿元海底电缆项目

36氪获悉,东方电缆公告,公司及全资子公司东方海工院近期收到相关通知书,确认公司及东方海工院联合体为相关项目中标人。其中,直流海底电缆项目中标金额约15.14亿元,交流海底电缆项目中标金额合计约24.72亿元,以上项目合计中标金额约40亿元。同日公告,公司拟以自有资金投资建设东方中央研究院·总部项目,项目总投资金额约为5.54亿元。

37分钟前

本页详细列出关于Osteoform乐力的品牌信息,含品牌所属公司介绍,Osteoform乐力所处行业的品牌地位及优势。
咨询